Funding
THORN, BRAIN
This study was funded by University of Birmingham, UK, from 1 August 2016. Further funding was sought and from 1 August 2019 an investigator-led grant was obtained from Invex therapeutics. J.L.M. was funded by the Ministry of Defence for the duration of the study. A.Y. was funded by an Association of British Neurologists and Guarantors of Brain fellowship. O.G. was funded by Brain research UK. Y.L. and N.H.G. are supported by the Intramural Research Program, National Institute on Aging, NIH (AG000333). A.J.S. was funded by a National Institute for Health Research (NIHR) clinician scientist fellowship (NIHR-CS-011-028) and the Medical Research Council, UK (MR/K015184/1) for the duration of the study. A.J.S. is funded by a Sir Jules Thorn Award for Biomedical Science. The views expressed are those of the authors and not necessarily those of the UK National Health Service, MoD, NIHR or the UK department of Health and Social Care. Role of Funder/Sponsor: The MoD, NIHR, MRC and Invex Therapeutics had no role in the design or conduct of the study; no role in collection, management or interpretation of the data; writing of the manuscript; and no role in the decision to submit the manuscript for publication.